Conference item
Validation of the survival model including cardiac substructure dosimetry in NSCLC
- Abstract:
- In lung cancer radiotherapy (RT) high doses are delivered to the heart. We found significant associations between death rate (DR) and high left atrial wall (LAWall) volumes receiving 63-69Gy (LAWallV63-69) and any new or worsening ischaemic or rhythm ECG changes within 6 months of RT in a prospective isotoxic dose-escalation trial of 78 locally advanced non-small cell lung cancer (LA-NSCLC) patients. Here we aim to validate these findings in an independent retrospective cohort.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 692.3KB, Terms of use)
-
- Publisher copy:
- 10.1016/S0167-8140(18)31057-0
Authors
- Publisher:
- Elsevier
- Host title:
- Radiotherapy and Oncology
- Journal:
- ESTRO 37 More from this journal
- Volume:
- 127
- Pages:
- S383-S384
- Publication date:
- 2018-06-18
- Acceptance date:
- 2018-02-09
- DOI:
- EISSN:
-
1879-0887
- ISSN:
-
0167-8140
- Pubs id:
-
pubs:900874
- UUID:
-
uuid:ed73b7c5-758d-4a9f-ab2e-dc09af9c68ea
- Local pid:
-
pubs:900874
- Source identifiers:
-
900874
- Deposit date:
-
2018-10-30
- ARK identifier:
Terms of use
- Copyright holder:
- Elsevier Ireland Ltd
- Copyright date:
- 2018
- Notes:
- Copyright © 2018 Elsevier Ireland Ltd. All rights reserved. Published under a Creative Commons License (CC BY-NC-ND)
If you are the owner of this record, you can report an update to it here: Report update to this record